Myocardial infarction accelerates atherosclerosis
Partha Dutta(University of Pittsburgh), Matthias Nahrendorf(Massachusetts General Hospital), Timo Heidt(Harvard University), Ying Wei(University of California, San Francisco), Claudio Vinegoni(Harvard University), Yoshiko Iwamoto(Harvard University), Michael T. Waring(Howard Hughes Medical Institute), Marc S. Sabatine(Brigham and Women's Hospital), Felix Lasitschka(Heidelberg University), James R. Stone(Harvard University), Filip K. Świrski(Allen Institute for Brain Science), Peter Libby(Harvard University), Anja M. van der Laan(University of Amsterdam), Jagdish Butany(University of Toronto), Hugo A. Katus(Heidelberg University), Charles P. Lin(Harvard University), David A. Morrow(University of California, San Francisco), Adam Chicoine(Howard Hughes Medical Institute), Hans W.M. Niessen(Vrije Universiteit Amsterdam), Ralph Weissleder(Massachusetts General Hospital), Florian Leuschner(Heidelberg University), Peter Waterman(Harvard University), Clinton S. Robbins(University Health Network), Michael A. Moskowitz(Harvard University), Martin Etzrodt(Center for Systems Biology), Gabriel Courties(Harvard University), Sabina A. Murphy(Brigham and Women's Hospital), Rostic Gorbatov(Harvard University), Maulik D. Majmudar(Harvard University), Barry B. Rubin(University of Toronto), Brian Thompson(Center for Systems Biology), Mikaël J. Pittet(University of Geneva), Alicia L. Carlson(Massachusetts General Hospital), Jan J. Piek(Amsterdam University Medical Centers)
Cited by 1,086
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k